Arrhythmias & electrophysiologyTrial design

Rationale and design of a multicenter randomized trial of adjunctive non-pulmonary vein trigger ablation in persistent atrial fibrillation: The EXPORT trial

Am Heart JPublished

  • multicenter, prospective, superiority, single-blinded, blinded-endpoint, clinical trial
  • randomized
  • rationale and design

Study context

Population
Participants with persistent atrial fibrillation (AF) refractory to AAD therapy undergoing first-time AF ablationestimated total sample size · pulmonary vein (PV) isolation with non-PV trigger provocation, mapping, and ablation 215 · PV isolation alone 215
Participants
430 participants
Planned comparison
systematic non-PV trigger ablation over PV isolation alone
  • PV isolation with non-PV trigger provocation, mapping, and ablationn = 215
  • PV isolation alonen = 215
Primary endpoint
any documented atrial arrhythmia lasting ≥30 s after a 3-month blanking period following ablation with or without the use of AADs

No results yet. This paper sets out the design of a trial; its results are to come.

Original publication

Rationale and design of a multicenter randomized trial of adjunctive non-pulmonary vein trigger ablation in persistent atrial fibrillation: The EXPORT trial. Am Heart J. Published 1 October 2026. doi:10.1016/j.ahj.2026.107624

Summarised from the published abstract; every number is checked against it